ATE418877T1 - Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung - Google Patents
Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzungInfo
- Publication number
- ATE418877T1 ATE418877T1 AT02736016T AT02736016T ATE418877T1 AT E418877 T1 ATE418877 T1 AT E418877T1 AT 02736016 T AT02736016 T AT 02736016T AT 02736016 T AT02736016 T AT 02736016T AT E418877 T1 ATE418877 T1 AT E418877T1
- Authority
- AT
- Austria
- Prior art keywords
- drinkable
- edible
- body temperature
- amino acid
- acid composition
- Prior art date
Links
- 230000036760 body temperature Effects 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000009697 arginine Nutrition 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 235000014304 histidine Nutrition 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 235000014705 isoleucine Nutrition 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 235000005772 leucine Nutrition 0.000 abstract 1
- 235000018977 lysine Nutrition 0.000 abstract 1
- 235000006109 methionine Nutrition 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 235000008729 phenylalanine Nutrition 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 235000004400 serine Nutrition 0.000 abstract 1
- 235000002374 tyrosine Nutrition 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 235000014393 valine Nutrition 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Seeds, Soups, And Other Foods (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001173983 | 2001-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE418877T1 true ATE418877T1 (de) | 2009-01-15 |
Family
ID=19015340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02736016T ATE418877T1 (de) | 2001-06-08 | 2002-06-06 | Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040235923A1 (de) |
EP (1) | EP1402788B1 (de) |
JP (1) | JP4128524B2 (de) |
KR (2) | KR100753879B1 (de) |
CN (1) | CN100464647C (de) |
AT (1) | ATE418877T1 (de) |
AU (1) | AU2008203461B2 (de) |
CA (1) | CA2449917C (de) |
DE (1) | DE60230621D1 (de) |
HK (1) | HK1064566A1 (de) |
NZ (2) | NZ587048A (de) |
TW (1) | TWI328450B (de) |
WO (1) | WO2002100193A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006191933A (ja) * | 2003-05-19 | 2006-07-27 | Ajinomoto Co Inc | いびき又は睡眠時の呼吸障害の予防・治療剤 |
WO2006049286A1 (ja) * | 2004-11-02 | 2006-05-11 | Ajinomoto Co., Inc. | アレルギー性疾患予防・治療剤 |
MX2007005136A (es) * | 2004-11-02 | 2007-08-02 | Oragenics Inc | Metodos para regular el peso y el tamano de los animales con glicina. |
WO2007029730A1 (ja) * | 2005-09-06 | 2007-03-15 | Meiji Dairies Corporation | 老人性貧血を防止又は治療するためのアミノ酸組成物 |
JPWO2007060924A1 (ja) * | 2005-11-22 | 2009-05-07 | 味の素株式会社 | 膵β細胞保護剤 |
JP5502480B2 (ja) * | 2006-09-18 | 2014-05-28 | コンピュゲン エルティーディー. | 生物活性ペプチド及びその使用方法 |
US20080268038A1 (en) * | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
JP5565016B2 (ja) * | 2009-04-08 | 2014-08-06 | ライオン株式会社 | 低体温改善用組成物及び冷え性改善用組成物 |
CN103181920A (zh) * | 2011-12-28 | 2013-07-03 | 吴顺字 | 一种防癌植物油的配方 |
JP6423717B2 (ja) * | 2012-05-07 | 2018-11-14 | 株式会社明治 | 非糖質性エネルギー産生増強剤 |
JP2016102064A (ja) * | 2013-08-14 | 2016-06-02 | 株式会社明治 | 脂質代謝促進剤 |
US9629889B2 (en) * | 2014-10-22 | 2017-04-25 | Khanh Le | Aqueous solution formulated to raise body temperature |
CN106417597A (zh) * | 2016-08-30 | 2017-02-22 | 新疆阜丰生物科技有限公司 | 一种适用于乳酸菌饮料的复合稳定剂 |
JP2017088616A (ja) * | 2017-02-09 | 2017-05-25 | 株式会社東洋新薬 | 黒生姜含有組成物 |
PL235153B1 (pl) * | 2017-06-02 | 2020-06-01 | Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia | Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN85105574A (zh) * | 1985-01-17 | 1987-01-14 | 四川大学 | 从牲畜血液中提制复合氨基酸的方法 |
CN86104864A (zh) * | 1986-07-30 | 1988-02-10 | 丹东市生物化学研究所 | 复合氨基酸提取方法 |
JPH0624976A (ja) * | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 輸液用組成物 |
DE69331528T2 (de) * | 1992-12-23 | 2002-10-31 | Abbott Laboratories, Abbott Park | Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern |
US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
EP0873754B1 (de) * | 1996-01-09 | 2003-07-30 | Riken | Aminosäurezusammensetzungen |
KR100481379B1 (ko) * | 1996-05-23 | 2005-05-16 | 오쓰까 세이야꾸 가부시키가이샤 | 체지방률을낮추고체조성을개선시키는식품조성물및체지방률을낮추고체조성을개선시키는방법 |
US6221836B1 (en) | 1996-07-26 | 2001-04-24 | Paxton King Beale | Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal |
ES2132021B1 (es) * | 1997-05-28 | 2000-02-16 | Riera Simon Schwartz | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. |
JPH10330264A (ja) * | 1997-06-02 | 1998-12-15 | Takeda Shokuhin Kogyo Kk | 脂質代謝促進組成物 |
JP3719478B2 (ja) * | 1998-03-13 | 2005-11-24 | 日本化薬株式会社 | ダイエット食品 |
JP2000228967A (ja) * | 1999-02-12 | 2000-08-22 | Bigguuesuto Sha:Kk | 脂質代謝加工食品 |
US7223417B2 (en) * | 2000-10-27 | 2007-05-29 | Calton Gary J | Nutrient formulations |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
-
2002
- 2002-06-06 CN CNB028152662A patent/CN100464647C/zh not_active Expired - Lifetime
- 2002-06-06 DE DE60230621T patent/DE60230621D1/de not_active Expired - Lifetime
- 2002-06-06 EP EP02736016A patent/EP1402788B1/de not_active Expired - Lifetime
- 2002-06-06 TW TW091112250A patent/TWI328450B/zh not_active IP Right Cessation
- 2002-06-06 JP JP2003503024A patent/JP4128524B2/ja not_active Expired - Lifetime
- 2002-06-06 CA CA002449917A patent/CA2449917C/en not_active Expired - Lifetime
- 2002-06-06 WO PCT/JP2002/005584 patent/WO2002100193A1/ja active Application Filing
- 2002-06-06 KR KR1020037016015A patent/KR100753879B1/ko active IP Right Grant
- 2002-06-06 KR KR1020077014498A patent/KR100852930B1/ko active IP Right Grant
- 2002-06-06 NZ NZ587048A patent/NZ587048A/en not_active IP Right Cessation
- 2002-06-06 NZ NZ569905A patent/NZ569905A/en not_active IP Right Cessation
- 2002-06-06 AT AT02736016T patent/ATE418877T1/de not_active IP Right Cessation
- 2002-06-06 US US10/479,605 patent/US20040235923A1/en not_active Abandoned
-
2004
- 2004-09-27 HK HK04107453.1A patent/HK1064566A1/xx not_active IP Right Cessation
-
2008
- 2008-08-01 AU AU2008203461A patent/AU2008203461B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JP4128524B2 (ja) | 2008-07-30 |
CN100464647C (zh) | 2009-03-04 |
KR100753879B1 (ko) | 2007-09-03 |
AU2008203461A1 (en) | 2008-08-21 |
EP1402788A1 (de) | 2004-03-31 |
KR100852930B1 (ko) | 2008-08-19 |
KR20040016880A (ko) | 2004-02-25 |
JPWO2002100193A1 (ja) | 2005-01-13 |
NZ569905A (en) | 2010-09-30 |
KR20070074002A (ko) | 2007-07-10 |
EP1402788B1 (de) | 2008-12-31 |
TWI328450B (en) | 2010-08-11 |
US20040235923A1 (en) | 2004-11-25 |
DE60230621D1 (de) | 2009-02-12 |
CA2449917C (en) | 2009-09-22 |
CN1538812A (zh) | 2004-10-20 |
AU2008203461B2 (en) | 2010-04-01 |
HK1064566A1 (en) | 2005-02-04 |
EP1402788A4 (de) | 2006-03-22 |
CA2449917A1 (en) | 2002-12-19 |
WO2002100193A1 (en) | 2002-12-19 |
NZ587048A (en) | 2012-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1629840A4 (de) | Aminosäure-zusammensetzung und flüssigkeitsersatz | |
ATE418877T1 (de) | Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung | |
CY1109304T1 (el) | Αμινοξεα με συναφεια για την αλφα-2-δελτα-πρωτεϊνη | |
WO2002062844A3 (en) | Long lasting growth hormone releasing factor derivatives | |
BRPI0512396A (pt) | polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente | |
PL344752A1 (en) | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof | |
ATE343332T1 (de) | Zusammensetzung, welche aminosäuren und trehalose enthält | |
ATE245999T1 (de) | Aminosäurezusammensetzungen | |
TW200634051A (en) | Processes for preparing a polypeptide | |
SE0002202D0 (sv) | New peptides | |
DE69922819D1 (de) | Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie | |
WO2007133642A8 (en) | Sport drink containing amino acids and carbohydrates | |
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
MX2009003126A (es) | Agente para prevenir/tratar el cancer. | |
PE20070033A1 (es) | Concentrado de proteina y flujo acuoso que contiene carbohidratos solubles de agua | |
NZ579566A (en) | Modified fgf-21 polypeptides and their uses | |
WO2005034932A3 (en) | Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function | |
HK1088849A1 (en) | Blood-viscosity reducing agent | |
DE60233558D1 (de) | Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber | |
WO2006005455A3 (en) | Amino, amino acid or peptide conjugates of retinoic acid | |
EP1908492A4 (de) | Metabotroper glutamat-rezeptor-aktivator | |
IN2015DN03883A (de) | ||
ATE245439T1 (de) | Inhibitoren für homöostase und immunfunktion | |
WO2001097785A3 (en) | Basic copolymers for the treatment of prion-related-disease | |
EP1641813A4 (de) | Verfahren zur herstellung von molekülen mit verminderter immunogenität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |